ArticleJournal of gastrointestinal oncology2023

The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the imRECIST: a single-center, retrospective study.

Kun-Li Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.